Longitude (Cayman) Ltd. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Longitude (Cayman) Ltd. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$211,000
-85.5%
15,000
-75.0%
0.31%
-77.3%
Q1 2022$1,453,000
-48.5%
60,000
-50.4%
1.38%
-8.4%
Q4 2021$2,824,000
-11.4%
121,000
-37.0%
1.51%
+7.1%
Q3 2021$3,189,000
-28.2%
192,000
+5.5%
1.41%
-33.2%
Q2 2021$4,439,000
-13.1%
182,000
-8.1%
2.10%
+7.6%
Q1 2021$5,108,000
-16.7%
198,000
+72.6%
1.96%
-33.4%
Q4 2020$6,132,000114,7002.94%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders